Oaktree Acquisition Corp. III Life Sciences (OACC) Change in Accured Expenses (2025)
Oaktree Acquisition Corp. III Life Sciences filings provide 1 years of Change in Accured Expenses readings, the most recent being -$90000.0 for Q4 2025.
- Quarterly Change in Accured Expenses changed N/A to -$90000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$40155.0 through Mar 2026, changed N/A year-over-year, with the annual reading at -$179984.0 for FY2025, 133.61% down from the prior year.
- Change in Accured Expenses hit -$90000.0 in Q4 2025 for Oaktree Acquisition Corp. III Life Sciences, down from $63977.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $63977.0 in Q3 2025 and bottomed at -$139829.0 in Q1 2025.